Pharmacotherapy of systolic heart failure: emphasis on mortality outcomes.
Mortality outcomes in clinical trials have become the foundation for the evidence-based management of patients with systolic heart failure. This review was intended to give the clinician a better understanding of newer pharmacological strategies in this patient population.